EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

AI could offer warnings about serious side effects of drug-drug interactions

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term orga...
Continue Reading →
Europe

New strategy to treat Parkinson’s disease

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harm...
Continue Reading →
Europe

Nurofen manufacturer Reckitt Benckiser under investigation by UK watchdog for selling ‘misleading’ painkillers

Drug company claims for over-the-counter painkillers are under investigation by a UK watchdog, The Independent has learnt.   The Advertising Standar...
Continue Reading →
Europe

Agilent contributes to research on performance enhancing spinach extract

Freie Universität Berlin uses company’s cutting-edge tools to examine effects of ecdysterone Agilent Technologies Inc. has announced that its instruments and exper...
Continue Reading →
news

HIV vaccine nears clinical trial following new findings

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide sim...
Continue Reading →
Europe

Velabs to develop novel immune-based therapy for obesity

Announces strategic partnership with alytas therapeutics Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeu...
Continue Reading →
Europe

IBD research smashes recruitment target two years early

by Anna Smith Cambridge University Hospital NHS Foundation Trust has announced that its inflammatory bowel disease (IBD) research has hit its recruitment target ...
Continue Reading →
Europe

Novartis announces positive results from two Entresto trials

by Anna Smith Novartis has announced results from two new clinical trials evaluating improvement in heart structure and function and long-term safety of Entresto...
Continue Reading →
Europe

NICE nod for Novartis’ Luxturna

by Anna Smith The National Institute for Health and Care Excellence (NICE) has recommended the use of Luxturna (voretigene neparvovec) on the NHS, Novartis has ann...
Continue Reading →
news

FDA Urges Inclusion Of Men In Breast Cancer Clinical Trials

Men with breast cancer have significantly fewer treatment options than women with the disease, partly due to exclusion from many clinical trials. A new document f...
Continue Reading →
Catalyst: 12th January 2026
Quotient